Mr. Suzuki is qualified to represent parties in court in IP infringement litigation. He has conducted research and development of pharmaceuticals, such as anti-platelet aggregation drugs and dihydropyridine type calcium channel antagonists, and also has experience in clinical development of medical equipment, such as balloon catheters and stent delivery systems for coronary arteries.